Progyny/PGNY

$33.06

1.1%
-
1D1W1MYTD1YMAX

About Progyny

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.

Ticker

PGNY

Sector

Healthcare

Trading on

NASDAQ

Industry

Healthcare Facilities

CEO

David Schlanger

Employees

563

Headquarters

New york, United States

Progyny Metrics

BasicAdvanced
$3.14B
Market cap
53.05
P/E ratio
$0.62
EPS
1.51
Beta
-
Dividend rate
$3.14B
1.50532
$44.95
$29.44
829.16K
3.444
45.682
9.55%
13.34%
13%
53.051
2.887
5.693
5.803
16.973
38.34%
102.72%
46.69%
9.53%

What the Analysts think about Progyny

Analyst Ratings

Majority rating from 10 analysts.
Buy

Price Targets

Average projection from 9 analysts.
41.17% upside
High $50.00
Low $43.00
$33.06
Current price
$46.67
Average price target

Progyny Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
4.96% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$269.9M
-3.88%
Net income
$13.4M
-15.19%
Profit margin
4.96%
-11.74%

Progyny Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 21.5%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.18
$0.15
$0.16
$0.13
-
Expected
$0.07
$0.10
$0.12
$0.11
$0.13
Surprise
142.31%
43.84%
36.59%
21.5%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Progyny stock?

Progyny (PGNY) has a market cap of $3.14B as of April 23, 2024.

What is the P/E ratio for Progyny stock?

The price to earnings (P/E) ratio for Progyny (PGNY) stock is 53.05 as of April 23, 2024.

Does Progyny stock pay dividends?

No, Progyny (PGNY) stock does not pay dividends to its shareholders as of April 23, 2024.

When is the next Progyny dividend payment date?

Progyny (PGNY) stock does not pay dividends to its shareholders.

What is the beta indicator for Progyny?

Progyny (PGNY) has a beta rating of 1.51. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Progyny stock price target?

The target price for Progyny (PGNY) stock is $46.67, which is 41.17% above the current price of $33.06. This is an average based on projections from 9 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Progyny stock

Buy or sell Progyny stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing